Anas lived in Jigawa State, Nigeria. When he was younger, he was infected by lymphatic filariasis (LF) – commonly known as elephantiasis.
Lymphatic filariasis, a neglected tropical disease (NTD) transmitted by mosquitoes, impairs the lymphatic system and can lead to the abnormal enlargement of body parts, causing severe pain, severe disability and social stigma. It is estimated that over 120 million people are affected by lymphatic filariasis worldwide.
Anas was unfortunately among the many in his community who have consistently missed out on the LF MDA (Lymphatic Filariasis Mass Administration of Medicines) programmes over the years, making him vulnerable to infection. As he grew older, he started to develop bilateral lymphoedema, severe swelling, in his legs.
He began to experience severe pain, as well as difficulty walking and weeping wounds on his legs. But luckily, he was enrolled in CBM’s CiSKuLA programme, which takes a comprehensive and inclusive approach to tackling the causes, symptoms and stigma of NTDs.
“As a result, his life was totally transformed – he learnt a trade, has a better understanding of washing and hygiene practices to prevent further infection, and he felt less ostracised in his community. He told his story in the uplifting film below; tragically he died this autumn, aged 19, and his story lives on as a beacon of hope for all those living with NTDs. .”
Find out more about Anas’ story, in his own words, here:
In 2024, QAV Ltd renewed their partnership with CBM, the Global Disability Inclusion Charity, through support of their Neglected Tropical Diseases (NTDs) programme, which tackles the causes, symptoms and stigma of NTDs in some of the world’s poorest communities.
